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ALLERGIC ECZEMATOUS SENSITIZATION IN MAN
1936 AND 1964*
RUDOLF L. BAER, MD.
The honor bestowed upon me by the mem-
bers of the Society for Investigative Derma-
tology when I was elected to the Presidency of
this Society has meant more to me than I can
tell you. For it is the very ideas upon which
the foundation of this Society were laid and
which have been guiding its activities for these
27 years that have determined my own con-
cepts of dermatology. My desire to enter the
specialty was first aroused by Marion Sulz-
berger at a time when he was deeply involved
in the founding of this Society and creating its
Journal. Indeed, my first piece of dermatologic
investigation was carried out in 1936 in col-
laboration with him and was published in Vol-
ume I of the Journal of Investigative Derma-
tology at its birth in 1938. It dealt with the
relationship between chemical structure and in
vitro properties and the capacities of 5 different
substituted nitrobenzenes to produce eczema-
tous sensitization in man (1).
We found at that time that the capacity of
these substances to produce contact-type
eczematous allergy in human beings closely
paralleled their skin-sensitizing ability when
injected intracutaneously into guinea pigs and
appeared to be related to the lability of their
Cl or NO2 groups and to their capacity to pro-
duce conjugates with autologous larger mole-
cules as demonstrated by Landsteiner and
Jacobs (2). That study was the first demonstra-
tion in man of a relationship between a chemi-
cal property demonstrable in vitro and the
capacity for producing eczematous contact
allergic sensitization. Among other interesting
findings in our study was that 1,3,5 trinitro-
benzene, although it had failed to produce
tuberculin-type sensitivity in man and in
guinea pigs (2), did occasionally produce ec-
zematous contact sensitization in man.
During the many years which have elapsed
* From the Department of Dermatology of the
New York University Schools of Medicine, New
York, N. Y.
Presented as the Presidential Address at the
Twenty-fifth Annual Meeting of the Society for
Investigative Dermatology, Inc., San Francisco,
Calif., June 21, 1964.
since 1936 the study of allergic eczematous con-
tact sensitivity has continued to be one of my
major interests. It appears appropriate to me,
therefore, that I should talk to you today about
a few arbitrarily selected aspects of the pres-
ent state of this problem and at the same time
to draw a few comparisons with the state of
knowledge in 1936. Many of the thoughts which
I shall express here in one form or another have
also been expressed or considered by others, in
particular by my friends Stephan Epstein,
Marion Sulzberger and Adolph Rostenberg, Jr.
Among the most interesting and important
problems in this area of immunology is the
relationship between allergic contact sensitiv-
ity and tuberculin-type sensitivity in man.
Since 1936 investigators in the fields of medicine
and immunology have become increasingly in-
terested in the delayed skin responses. They, as
well as dermatologists today, are profoundly con-
cerned with the relationship between eczema-
tous contact allergy and tuberculin-type allergy.
If one reads the publications of immunologists
who have done their investigative work exclu-
sively on guinea pigs, who have had little or
no opportunity to observe contact dermatitis in
man and who only consider immunologic fac-
tors one has the impression that there is a very
simple relationship between these two forms of
reactivity, namely that they are practically
alike. For example, the hypothesis that the
major difference is one of carrier specificity (3)
considers only differences in antigenic deter-
minants but fails to take account of the very
important characteristics of the reacting tis-
sues. This hypothesis fails to account for a
number of important observations including,
for example, the fact that contact sensitivity
cannot be engendered in certain species of
laboratory animals in which tuberculin-type
sensitivity can be readily induced (e.g. in
rabbits).
Due to the concept of identity of contact and
tuberculin-type sensitization, studies on contact
sensitivity in quinea pigs which have been done
during the past two decades have often in-
volved sensitizing exposures by routes other
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than contact. Here one must ask: Is it really
immaterial if one sensitizes by contact or injects
the simple chemical compound in Freund's
emulsion into the foot pad or intraperitoneaily,
or if one conjugates the simple chemical with
erythrocyte stromata and then injects this con-
jugate intraperitoneally? No doubt a high
incidence and strong degree of sensitization can
be brought about by these procedures (4, 5).
But is one justified to consider sensitizations
produced by these unphysiologic routes and
means of exposure identical with cczematous
contact sensitivity as seen in man? It would
seem to me that much of the evidence developed
since 1936 would tend to make the answer to
this question emphatically "no".
In 1936 it was already well known that great
differences existed in the capacity of small mo-
lecular substances to engender contact allergy.
In man contact sensitivity in an overwhelming
percentage of cases arises after exposure via
contact. The incidence of allergic contact sen-
sitivities after oral or parenteral administra-
tion of simple chemicals is extremely low,
considering the tremendous opportunities for ex-
posures to potential allergens via these routes.
However, as a result of the several sensitizing
methods devised since then to artifically in-
crease the incidence of sensitization to simple
chemicals in laboratory animals, these differ-
ences have become much less conspicuous. Even
compounds which under ordinary conditions
produce an extremely low incidence of sensitiza-
tion in man and guinea pigs induce a substantial
incidence of sensitization in guinea pigs under
these artificial conditions. This suggests that
when these artificial methods are used, the
mechanism of sensitization involves links which
are not part of ordinary contact sensitization
in man. One possible link is the accumulation
of macrophages in the area where the antigen
is concentrated after its administration in
Freund's adjuvant.
The work of Fishman et al. (6) in guinea
pigs suggests that it is RNA-antigen complexes
from stimulated macrophages which engender
antibody production by the lymphocytic cells.
It is interesting to note in this connection that
Rostenberg in 1947 (7) suggested that the high
incidence of sensitizations after application of
the allergen to the skin may be due to the rich-
ness of the cutis in macrophages.
The route and means of exposure have taken
on greater significance also in view of the more
modern concepts regarding the role of the
carrier protein in contact allergy. In 1936 simple
chemicals were known to be only partial antigens
(haptens) (8) and it was assumed that to be-
come fully antigenic these haptens first must
conjugate with larger molecular aggregates
(carriers-Schieppers). What was not known,
however, was whether or not they also must
first conjugate with such carriers in order to
elicit a reaction in already sensitized skin. Al-
though this point remains under dispute, it now
appears likely that contact allergens also must
conjugate to elicit a reaction (9). This is par-
ticularly significant because present concepts of
the role of the carrier protein are different from
those held earlier when it was assumed that
the specificity of the complex allergen was to a
great degree independent of the nature of the
protein (10).
A considerable amount of evidence has since
accumulated, however, to support the concept
that the carrier protein in "delayed" sensitivity,
including contact allergy, also provides anti-
genie determinants. Such a role for the protein
carrier was proposed by Stephan Epstein in
1952 (11) on the basis of clinical observations.
Experimental support for this was provided by
Gell and Benacerraf (3) who in 1961 reported
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that guinea pigs sensitized by injection of un-
conjugated picryl chloride plus adjuvants
tend to react more to contact with picryl chlo-
ride than to intradermally injected picryl
conjugate, while guinea pigs sensitized with a
picryl conjugate plus adjuvants give poorer
contact than intradermal reactions. They also
observed that the degree of reaction to intra-
dermally injected picryl conjugates was about
the same in animals sensitized with picryl
conjugates regardless of whether the conjugates
were made with homologous serum, homologous
skin or heterologous protein. However, the
contact sensitivity of the same animals differed
somewhat depending on the nature of the pro-
tein carrier, in that a greater degree of con-
tact sensitivity developed in animals injected
with homologous than with heterologous con-
jugates. They defined contact sensitivity as a
"form of delayed cellular sensitivity to autol-
ogous conjugates, indistinguishable in its im-
munologic mechanism from other classic forms
of delayed sensitivity to proteins."
If in contact sensitivity part of the carrier
protein is of such importance as an antigenic
determinant, one would think that the route of
exposure during the sensitization process and in
elicitation is of considerable significance, since
this route determines the proteins which are
available as carriers and their structures in turn
determine the nature of the antigenic complexes
which are formed. Are the antigenic complexes
formed in the foot pad of a guinea pig in the
presence of tubercie bacilli and other foreign
materials necessarily the same as the antigenic
complexes formed with the fibrous proteins
(12) of the epidermis and/or dermis (pro-
keratins, keratins, procollagens, collagens)?
In this connection it would be of great in-
terest to know what happens when the sensi-
tizing exposure to the unconjugated compound
takes place directly in the lymph node, thus
depriving the allergen of the opportunity to
conjugate with the fibrous proteins specifically
of the epidermis and dermis. Obviously no such
experiments have been done in man, but several
investigators examined this problem in guinea
pigs with contradictory results. Seeberg (13)
reported that contact sensitivity could be
engendered in this manner and this has recently
been confirmed by Macher and Sennlaub (14).
However, Frey and Geleick (15) were unable
to induce contact sensitivity in guinea pigs by
injecting dinitrochlorobenzene directly into the
lymph node. To my knowledge no experiments
have ever been done using injections of
hapten-protein conjugates into lymphnodes.
The findings of Frey and Geleick would fit
in with the hypothesis that the protein carrier
is important in determining the specificity of
the antigenic complex. If, however, there is
validity in the reports that contact sensitivity
can readily be engendered by injection of the
hapten directly into the lymph node, a number
of possible explanations, including the following,
will have to be considered:
(1) there is constant drainage of epidermal
and dermal proteins from the skin into the re-
gional lymph nodes providing an opportunity for
conjugation of the hapten with the "right" pro-
teins.
(2) there is leakage of hapten from the in-
jected lymph node back into the skin despite
efforts of the investigators to prevent such
leakage.
(3) there is leakage from the injection site in
the lymph node into the blood stream and from
there unconjugated or loosely conjugated hapten
reaches the skin.
(4) the characteristics of the carrier protein
are not as important in determining specificity
as has been believed in recent years.
In 1928 the relationship of allergic contact
sensitivity to delayed tuberculin-type sensitiv-
ity already had aroused the interest of W. Frei
(16). Subsequently, this question was subjected
to study by many others including Blumenthal
and Jaffe (17) and Pascher and Sulzberger (18),
but not until 1956, did Stephan Epstein (19) first
introduce the concept of contact dermatitis
based exclusively on dermal delayed (tuber-
culin-type) sensitivity. Among the allergens re-
ported to have engendered dermal contact
sensitivity were compounds as different as
neomycin, nickel, gentian violet and ragweed
oleoresin. Such dermal contact sensitivity is de-
monstrable by a positive intradermal test. Clinic-
ally, the lesions of dermal contact dermatitis
are edematous and erythematous rather than
papulovesicular. Correspondingly the histologic
changes consist of a normal epidermis and of
edema and slight cellular infiltration in the
papillary layer and dense perivascular small
round cell infiltration in the dermis.
I would like at this point to define some terms
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as I shall use them here. "Dermal" contact
sensitivity implies an allergic reaction elicited
by contact but taking place in the dermis; it
corresponds to the delayed tuberculin-type
sensitization to microbial agents. The term
ueczematous"* contact sensitivity also implies
an allergic reaction elicited by contact, but one
which takes place in the epidermis in the form
of papulo-vesiculation and histologically shows
spongiosis.
It is obvious that most cases of contact
dermatitis seen clinically are combinations of
an eezematous and a dermal sensitivity. In-
deed, everyone seems to agree that under suit-
able conditions one can often demonstrate both
an eczematous patch test reaction and a
dermal intracutaneous test reaction in cases of
allergic contact dermatitis. In addition to Ep-
stein's report there are others describing purely
dermal contact dermatitis with only an intra-
cutaneous test reaction (20). Cases of purely
eczematous contact dermatitis with only a
patch test reaction have also been reported. In
addition to our own findings with 1,3,5 trinitro-
benzene (1), I need only cite the publications
of Pascher and Sulzberger (18) and Stephan
Epstein (19). I might also report that in a
series of 11 cases of nickel contact sensitivity
recently tested with 1: 1000 aqueous solution of
nickel sulfate in my Department there were 7
with both types of reaction, 4 with only an ecze-
matous reaction and none with only a dermal re-
action.
Some of the differences in the findings of vari-
ous investigators can be explained by differences
in the concentrations of patch and intra-
cutaneous test materials, in technies (e.g. the
depth of the intracutaneous injection), in
schedules of time intervals for test readings
(21) and perhaps also by primary irritaney
of some of the intracutaneous test materials.
As a matter of fact, it appears that perhaps
this question can be completely resolved only
by means of histologic examinations of patch
and intracutaneous test sites after various time
intervals. It seems to me that among the com-
ponents which must be considered in the
mechanism which mediates allergic contact re-
*UEczematous is much more preferable to
"epidermal" not only for reasons of tradition but
also because of the two "eczematous" more clearly
denotes the characteristics of this form of reac-
tion.
actions in the skin there are several which are
preeminent:
TABLE II
Preeminent components in the allergic
contact reaction
The antigens and their hapten conjugates with
locations in the epi.. epidermal proteins
dermis and/or dermis: (HCEP)
hapten conjugates with
dermal proteins
(HCDP)
The cellular antibodies antibodies to HCEP
and their locations in antibodies to HCDP
the epidermis and/or
dermis:
The reacting tissues epidermis
dermis
What is likely to happen when these and
other factors interact? No certain answer can
be given now because of the large gaps in
knowledge. Take for example the question
whether the immunologically competent cells
react directly with TICEP and IICDP; or
whether they first must pass their reactive fac-
tor on to epidermal and dermal cells, in which
case the antigen-antibody interaction probably
would take place at the surface of the skin cells.
The answer to this alone would have a profound
influence on the site and character of the re-
action which ensues.
Other questions that arise are: What is the
exact role of the tissue mast cell (22) and of
the circulating blood basophil (23, 24) in the
allergic contact reaction? Do the HCEP or
HCDP antigens cause a reaction only where
they are formed or do they diffuse from the
epidermis into the dermis or from the dermis
into the epidermis? The rare occurrence of
exclusively eczematous and exclusively dermal
sensitization suggests a lack of diffusabiity of
the antigenic complexes at least in some cases.
For example, in dermal contact dermatitis the
allergen must pass through the epidermis with-
out eliciting any detectable changes. HCDP are
formed in the dermis and due to apparent lack
of diffusion elicit a reaction only in the dermis.
If this is so, then the very pronounced epidermal
involvement which occurs in the vast majority
of cases of clinical allergic contact dermatitis
denotes formation of HCEP. Another possible
though improbable explanation is that the
ALLERGIC ECZEMATOUS SENSITIZATION IN MAN 227
epidermis in dermal contact sensitivity lacks
immunologically competent lymphocytes or re-
action-mediating basophils rather than antigenic
complexes.
Then comes the question: Why do most
persons who develop allergic contact dermatitis
become allergic to both HCEP and HCDP,
while only a few become allergic to HCEP
or HCDP? The answer to this is just as elusive
as the explanation that one person becomes
urticarially allergic to penicillin while another
becomes urticarially allergic to acetylsalicylic
acid. Perhaps genetic factors which were
shown to exist in contact sensitization in guinea
pigs by Chase (25) and more recently also in
dermal sensitization by Levine et al. (26), also
determine these susceptibilities in human be-
ings.
In any event it would seem that pure eczema-
tous sensitivity as was proposed by Epstein (10)
is delayed sensitivity based on a reaction of cellu-
lar antibodies with epidermal conjugates of con-
tact allergens in the epidermis leading to damage
to epidermal cells and consequent development
of histologic spongiosis and clinically papulo-
vesicular eczema. Pure dermal sensitivity is de-
layed sensitivity based on a reaction of cellular
antibodies with dermal conjugates of contact
allergens in the dermis leading histologically to
extravasation of fluid and cells and clinically
to erythema and edema.
Perhaps this difference between eczematous
and dermal contact sensitivity also explains
some of the differences in the results of cellular
passive transfer of contact sensitivity in man
as reported in the literature and the differences
in cellular passive transfer of contact sensitiv-
ity between man and guinea pigs (27). While
there appears to be no question about the
transferability of tuberculin-type sensitivity in
man (28), the results in contact sensitivity have
been contradictory, some having been success-
ful (29) where others failed (30). Of particular
interest in this connection are the results of
Haxthausen (31) which suggest that he pro-
duced passive local skin sensitivity of the der-
mal type but not of the eczematous type by
means of cells from freshly excised lymph nodes
of sensitive donors. It appears possible then
that those cases of contact allergy which permit
cellular passive transfer are cases with a strong
"dermal" component (32) and those which
cannot be passively transferred are cases of
TABLE III
The principal differences between pure forms of
eczematous and dermal contast sensitization*t
Eczematous Dermal
Antigenic HCEP IICDP
complexes
Reacting tis- epidermis dermis
sues
Skin tests patch test
positive
intracutaneous
test negative
intracutaneous
test positive
patch test
negative
Cellular pas- negative? positive
sive transfer
Clinical fea- eczematous erythema,
tures (papulo-
vesicular)
edema
Histologic spongiosis; in- edema and
features traepidermal
vesicles
small round
cell infiltrate
in dermis
* Most clinically seen cases of allergic contact
dermatitis probably are mainly eczematous with
a dermal component. Pure forms are the exception.
f For purposes of simplicity the role of appen-
dageal materials is omitted.
pure eczematous allergy or of strong eczematous
allergy associated with a very weak dermal
component. Table III summarizes these differ-
ences.
Considerable caution is, of course, indicated in
applying the results of experiments in guinea
pigs to eczematous contact allergies in man.
What is called contact sensitivity in the guinea
pig grossly and histologically has many of the
earmarks of dermal contact sensitivity in man.
Gross papulo-vesicular eczematous lesions, the
hallmark of eczematous contact sensitivity in
man, are never seen on the skin of guinea pigs
and histologically also are not characteristic ex-
cept under artificial conditions such as applica-
tion of the allergen to the nipple (33) or to skin
areas which deliberately have been made
acanthotic (34). This is probably due in part
to anatomic factors, i.e. the meager layers of
keratinoeytes, but this same feature in the
guinea also denotes a paucity of available fibrous
epidermal proteins for formation of UCEP.
Two phenomena seen in allergic contact
dermatitis in man have fascinated me for many
years because of the difficulty in explaining them
on the basis of persent concepts of mononuclear
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cells carrying cellular antibodies to all parts
of the integument. The first of these is the very
rare phenomenon of allergic sensitivity re-
stricted to a small area of the skin, e.g. on
hands or feet. The second, less rare, phenomenon
is that of specifically much greater sensitivity
of one or more skin areas in patients with gen-
eralized contact allergy. These localized areas
flare up, without being directly exposed, when
the allergen is applied to distant sites. At times
such areas are sites of previous clinical in-
volvement with contact dermatitis or of patch
tests with the homoloqotts allergen. Apparently
this reaction is elicited by minute amounts of
allergen which reach these sites via the blood or
lymph circulation.
Can it be assumed that only these limited
areas of skin have the capacity to accept, con-
centrate or fix sufficient numbers of immuno-
logically competent cells? Or is it that only
these restricted areas provide the appropriate
proteins for hapten conjugation? Or, again, is
it as Epstein (11) suggested that only the
reticulo-endothelial system in these particular
skin locations provides the "right" clones of
competent cells capable of forming cellular
antibodies to the particular hapten-protein
conjugate? If so, this could account for ade-
quate provision of immunologically competent
cells in these skin sites only. In the past at-
tention was focussed only on the regional
lymphnodes while the role of the skin's own
reticulo-endothelial system in allergic contact sen-
sitization largely escaped consideration.
There are many other unsolved problems
which are at present of particular interest in
connection with allergic contact dermatitis, but
time does not permit me to discuss them here.
Among them are the role of the blood basophils
and of the tissue mast cells, the problem of asso-
ciated sensitivity of the mucous membranes, the
problem of cross-reactivity between cellular
antibodies to hapten conjugates with epidermal
and derinal proteins and the problems of spe-
cific acquired tolerance and of specific hypo-
sensitization.
In our article in the first volume of the
Journal of Investigative Dermatology, SuIz-
berger and I made the following statement, which
in view of the developments since 1936 seems
even more significant now than it was then:
"The eczematous contact-type of reaction of
the human skin is a form of allergy with special
and peculiar characteristics which are not
necessarily identical with the cutaneous hyper-
sensitivity demonstrated in guinea pigs by
means of intracutaneous injection or even ex-
ternal application of allergens". In 1964 allergic
eczematous contact sensitization shares many,
although not all, features of other forms of de-
layed sensitivity and remains a unique form
of delayed allergic sensitization occurring in the
skin of man.
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